Reading time is <1 mins
.
.
IN INDIA, CORONA BANGS: BLACK MUSHROOM
In India, where the outbreak is progressing most rapidly, cases of mucormycosis, also known as the ‘black fungus’, along with the corona virus, have also increased. Experts believe the deadly infection, which went as far as the removal of the eye, was triggered by steroid drugs used to treat the corona virus, especially in diabetes patients.
While the corona virus is rapidly dying around the world, India is one of the countries hit hardest by the outbreak in recent weeks. Another danger arose among patients in a country where the number of new cases did not fall below 300 thousand for days, the health system collapsed and the crisis of medical equipment.
The disease, which increases with the corona virus, is mucormycosis, also known as ‘black fungus’. An eye surgeon who served in three hospitals in Mumbai, Dr. said he had faced 40 cases of black fungus in the past month. Dr. said that this figure is very high, he has only seen 10 cases in the last 2 years.
.
11 PATIENTS ‘ EYES REMOVED
The disease occurs after an average of two weeks in people who have experienced Covid-19, Business Insider reported. The vast majority of the people in question are patients with diabetes. So that the infection does not spread to the body, doctor 11 of patients had their eyes removed. The death rate from the disease is 50 per cent.
In the world’s second most populous country, the health sector has come to a standstill, with the number of cases and deaths rising.
.
STEROID DRUGS TRIGGER
Dr. said he believed one of the main factors in triggering the disease was the steroid drugs used to treat the corona virus. Steroid drugs prevent lung damage and work in severe patients, said Dr. testified that he put his immune system under pressure. Dr. “Diabetes lowers body resistance, the corona virus exacerbates it, while steroids that help combat Covid-19 are like pouring gasoline on fire,” was said.
The rate of diabetes in India is very high and it is very difficult to keep it under control, said a professor from the University of Manchester Dr. said: “there are cases of mucormycosis that have also been reported in other countries. These include the United Kingdom, the United States, France, Austria, Brazil and Mexico,” he said.
.
SYMPTOMS OF THE DISEASE
Among the symptoms of ‘black fungus’ or mucormycosis, according to data released by the US Centers for Disease Control and Prevention (CDC), are;
– Swelling on one side of the face.
– Headache.
– Congestion in the nose and sinuses.
– High fever.
– Blackening of the nose.
– Chest pain and shortness of breath.
.
MUTATION IN INDIA GLOBAL THREAT
On the other hand, the World Health Organization (WHO), which continues its work within the United Nations, said that a new type of corona virus, first found in India last year, has spread more easily than some preliminary studies, and that this species has begun to pose a global threat.
B.The variant, designated 1.617, will be the fourth type of corona virus seen as a threat on a global scale. Other globally threatened species of the corona virus were the UK, South Africa and Brazil.
”We classify it as a species that poses a threat at a global level,“ said, who’s technical chief in charge of the corona virus. ” there is some information available that there is higher contagion.”
Cases of corona virus in India and the number of people who died from the corona virus approached a Daily Record yesterday.
In India, the world’s second most populous country, 366,161 new cases of corona virus were detected yesterday, while 3,754 people died from the virus. The total number of Covid-19 cases in the country, where hospital beds, morgues and crematoriums have exceeded capacity, rose to 22.66 million, while the total number of deaths was 246,116.
Who, B.It said the new species, named 1,617, was first seen in India in December last year. Because this new species in India has already spread to other countries, many countries have limited travel with India.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.